Ignyte Acquisition (IGNY) Stock Price, News & Analysis

Company Overview

Ignyte Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intends to focus on target businesses in the life sciences, biotechnology, and healthcare sectors. Ignyte Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.02 to $13.05
• 52-Week Range: N/A
• Volume: 177,600 shs
• Average Volume: 26,174 shs
• Market Capitalization: $95.00 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 4/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: N/A
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:IGNY
• Previous Symbol: NASDAQ:IGNY
• CIK: 1834645
• Web: ignytespac.com
• Phone: 212-409-2000
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-490,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: 365.46%
• Return on Assets: -0.83%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.14
• Quick Ratio: 0.14

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.28) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,280,000
• Free Float: 5,831,000
• Market Cap: $95.00 million
• Optionable: Not Optionable
• Beta: 0.19